CLINICAL_TRIALS
trial_result
· 2019-04-24
Clinical Trial Update: Glutamatergic Modulation of Motivation Enhancement: A Pilot Feasibility Trial [Phase 1, Phase 2]
Summary
A pilot feasibility trial exploring glutamatergic modulation to enhance motivation in cocaine use disorders; study completed with results posted in 2019.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: New York State Psychiatric Institute | Conditions: Cocaine Use Disorders | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2019-04-24